Sustained Virologic Response

"Sustained Virologic Response" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.

Descriptor ID	D000072230
MeSH Number(s)	E01.789.800.570 N04.761.559.590.800.665 N05.715.360.575.575.800.665
Concept/Terms	Sustained Virologic Response Sustained Virologic Response Response, Sustained Virologic Sustained Virologic Responses Virologic Response, Sustained Sustained Viral Suppression Suppression, Sustained Viral Sustained Viral Suppressions

Below are MeSH descriptors whose meaning is more general than "Sustained Virologic Response".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Prognosis [E01.789]
Treatment Outcome [E01.789.800]
Sustained Virologic Response [E01.789.800.570]
Health Care [N]
Health Services Administration [N04]
Quality of Health Care [N04.761]
Outcome and Process Assessment (Health Care) [N04.761.559]
Outcome Assessment (Health Care) [N04.761.559.590]
Treatment Outcome [N04.761.559.590.800]
Sustained Virologic Response [N04.761.559.590.800.665]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Outcome and Process Assessment (Health Care) [N05.715.360.575]
Outcome Assessment (Health Care) [N05.715.360.575.575]
Treatment Outcome [N05.715.360.575.575.800]
Sustained Virologic Response [N05.715.360.575.575.800.665]

Below are MeSH descriptors whose meaning is related to "Sustained Virologic Response".

Below are MeSH descriptors whose meaning is more specific than "Sustained Virologic Response".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Sustained Virologic Response" by people in this website by year, and whether "Sustained Virologic Response" was a major or minor topic of these publications.

Bar chart showing 6 publications over 6 distinct years, with a maximum of 1 publications in 2016 and 2017 and 2018 and 2019 and 2020 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2016	0	1	1
2017	1	0	1
2018	0	1	1
2019	0	1	1
2020	0	1	1
2021	0	1	1

Below are the most recent publications written about "Sustained Virologic Response" by people in Profiles.

Turgeon MK, Shah SA, Delman AM, Tran BV, Agopian VG, Wedd JP, Magliocca JF, Kim A, Cameron A, Olyaei A, Orloff SL, Anderson MP, Kubal CA, Cannon RM, Locke JE, Simpson MA, Akoad ME, Wongjirad CP, Emamaullee J, Moro A, Aucejo F, Feizpour CA, Vagefi PA, Nguyen MH, Esquivel CO, Dhanireddy K, Subramanian V, Chavarriaga A, Kazimi MM, Anderson MS, Sonnenday CJ, Kim SC, Foley DP, Abdouljoud M, Salgia RJ, Moris D, Sudan DL, Ganesh SR, Humar A, Doyle M, Chapman WC, Maithel SK. Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Ann Surg. 2021 10 01; 274(4):613-620.

View in: PubMed
McManus M, Karalius B, Patel K, Persaud D, Luzuriaga K. Quantitative HIV-1-specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations. AIDS. 2020 07 01; 34(8):1117-1126.

View in: PubMed
McManus M, Henderson J, Gautam A, Brody R, Weiss ER, Persaud D, Mick E, Luzuriaga K. Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy. Clin Infect Dis. 2019 05 02; 68(10):1725-1732.

View in: PubMed
Kouris G, Hydery T, Greenwood BC, Lavitas P, Price M, Clements K, Alper CJ, Lenz K, Jeffrey PL. Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population. J Manag Care Spec Pharm. 2018 Jul; 24(7):591-597.

View in: PubMed
Spooner LM, Abraham GM. Sustained virological response in a treatment-experienced patient with hepatitis C virus genotype 6 infection: Follow-up on a reported case. Am J Health Syst Pharm. 2017 04 15; 74(8):555.

View in: PubMed
?sbj?rnsd?ttir KH, Hughes JP, Wamalwa D, Langat A, Slyker JA, Okinyi HM, Overbaugh J, Benki-Nugent S, Tapia K, Maleche-Obimbo E, Rowhani-Rahbar A, John-Stewart G. Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children. AIDS. 2016 11 28; 30(18):2835-2843.

View in: PubMed
Smith HL, Chung RT, Mantry P, Chapman W, Curry MP, Schiano TD, Boucher E, Cheslock P, Wang Y, Molrine DC. Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study. J Viral Hepat. 2017 03; 24(3):197-206.

View in: PubMed

People

Explore

Similar Concepts

Top Journals